Factors associated with subendocardial ischemia risk in patients on hemodialysis

Factors associated with subendocardial ischemia risk in patients on hemodialysis

Abstract Introduction: Bone metabolism disorder (BMD) and vascular dysfunction contribute to excess cardiovascular mortality observed in hemodialysis patients. Vascular dysfunction, a new marker of atherosclerosis, can play a role in this risk. Even though associated with higher mortality in the ge...

Full description

Bibliographic Details
Main Authors:	Bruno Caldin da Silva, Adriano Sanjuan, Valéria Costa-Hong, Luciene dos Reis, Fabiana Graciolli, Fernanda Consolim-Colombo, Luiz Aparecido Bortolotto, Rosa Maria Affonso Moyses, Rosilene Motta Elias
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Nefrologia
Series:	Brazilian Journal of Nephrology
Subjects:	cardiovascular system hyperparathyroidism, secondary renal dialysis
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002016000300320&lng=en&tlng=en

Similar Items

Effectiveness and safety of a 6-month treatment with paricalcitol in patients on hemodialysis with secondary hyperparathyroidism
by: Inés Olaizola, et al.

Impact of Subtotal Parathyroidectomy on Clinical Parameters and Quality of Life in Hemodialysis Patients with Secondary Hyperparathyroidism
by: Mohamed Mimi Abd Elgawwad El-kholey, et al.
Published: (2019-12-01)

Role of etelcalcetide in the management of secondary hyperparathyroidism in hemodialysis patients: a review on current data and place in therapy
by: Friedl C, et al.
Published: (2018-06-01)

Результати динамічного когортного спостереження функції паращитоподібних залоз у пацієнтів із вторинним гіперпаратиреозом
by: N.V. Karlovich
Published: (2015-02-01)

Risk factors associated with subendocardial ischemia in hemodialysis patients
by: Cristina Karohl

The deceptive concept of hypoparathyroidism and recurrence after parathyroidectomy in dialysis patients: are we offering a Procrustean bed to some patients?
by: FABIO LUIZ DE MENEZES MONTENEGRO, et al.

Management of chronic kidney disease–mineral and bone disorder: Korean working group recommendations
by: Eunah Hwang, et al.
Published: (2015-03-01)

Fluid overload after coronary artery bypass graft in patients on maintenance hemodialysis is associated with prolonged time on mechanical ventilation
by: Sirlei Cristina da Silva, et al.
Published: (2020-03-01)

Thyrotoxicosis Occurring in Secondary Hyperparathyroidism Patients Undergoing Dialysis after Total Parathyroidectomy with Autotransplantation
by: Zhou Xu, et al.
Published: (2017-01-01)

Comparison between Calcitriol and Calcitriol Plus Low-Dose Cinacalcet for the Treatment of Moderate to Severe Secondary Hyperparathyroidism in Chronic Dialysis Patients
by: Chien-Te Lee, et al.
Published: (2013-04-01)

Evaluation of laboratory parameters and symptoms after parathyroidectomy in dialysis patients with secondary hyperparathyroidism
by: Yi Zhang, et al.
Published: (2019-01-01)

Incidence of and risk factors for post-parathyroidectomy hungry bone syndrome in patients with secondary hyperparathyroidism
by: Kittrawee Kritmetapak, et al.
Published: (2020-01-01)

Clinical and microbiological effects of dialyzers reuse in hemodialysis patients
by: Isabella Carvalho Ribeiro, et al.
Published: (2019-01-01)

A rare cause of subendocardial ischemia
by: Inês Almeida, et al.
Published: (2015-06-01)

Pro-inflammatory cytokines and bone fractures in CKD patients. An exploratory single centre study
by: Panuccio Vincenzo, et al.
Published: (2012-10-01)

Intermittent Oral Versus Intravenous Alfacalcidol in Dialysis Patients
by: Mitwalli Ahmed, et al.
Published: (2000-01-01)

Parathyroid Hormone: A Uremic Toxin
by: Eduardo J. Duque, et al.
Published: (2020-03-01)

Cinacalcet in peritoneal dialysis patients: one-center experience
by: Sara Querido Conde, et al.

Vitamin D prohormone in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease
by: Friedl C, et al.
Published: (2017-05-01)

Managing hyperparathyroidism in hemodialysis: role of etelcalcetide
by: Eidman KE, et al.
Published: (2018-02-01)

Etelcalcetide: Un Nuovo Calciomimetico Per la Terapia Dell'Iperparatiroidismo Secondario Nei Pazienti in Emodialisi
by: Monica Limardo, et al.
Published: (2017-02-01)

Depression in hemodialysis patients: the role of dialysis shift
by: Flavio Teles, et al.
Published: (2014-03-01)

Use of Recombinant Human Parathyroid Hormone to Treat Hungry Bone Syndrome in Hemodialysis Patient
by: Chaaban Ahmed, et al.
Published: (2020-07-01)

Cytokine accumulation in osteitis fibrosa of renal osteodystrophy
by: Duarte M.E.L., et al.
Published: (2002-01-01)

Comparative efficacy and safety of paricalcitol versus vitamin D receptor activators for dialysis patients with secondary hyperparathyroidism: a meta-analysis of randomized controlled trials
by: Yifeng Xie, et al.
Published: (2017-08-01)

Changes of Serum Total and Free Testosterone Concentrations in Male Chronic Hemodialysis Patients with Secondary Hyperparathyroidism in Response to Cinacalcet Treatment
by: Piotr Kuczera, et al.
Published: (2016-01-01)

Efficacy of low-dose cinacalcet on alternate days for the treatment of secondary hyperparathyroidism in hemodialysis patients: a single-center study
by: Gojaseni P, et al.
Published: (2017-02-01)

Analysis of Risk Factors for Development of Cognitive Disorders in Maintenance Hemodialysis Patients – Pilot Study
by: Jovanovic Milena, et al.
Published: (2017-12-01)

The evaluation of hemodialysis adequacy during the use of different dialysis membranes
by: Stašević Zvonimir, et al.
Published: (2007-01-01)

Investigating patients with normocalcemic hyperparathyroidism: When is a parathyroid scintigraphy indicated?
by: Elias E Mazokopakis, et al.
Published: (2019-01-01)

Prevalence of Secondary Hyper Parathyroidism in Hemodialysis Patients
by: F Behzad, et al.
Published: (2007-04-01)

Comparison of Paricalcitol (I.V) and Alfacalcidol (I.V) in Treatment of Secondary Hyperparathyroidism (SHPT) in Hemodialysis Patients
by: Mansoor Abbas Qaisar, et al.
Published: (2020-12-01)

Comparison Of Monocyte / HDL Ratio In Routine Hemodialysis And Peritoneal Dialysis Patients
by: Alper, et al.
Published: (2020-03-01)

Influência do hiperparatireoidismo secundário grave no estado nutricional de pacientes com insuficiência renal crônica Influence of severe secondary hyperparathyroidism in the nutritional status of patients with chronic renal failure
by: Bárbara Santarosa Emo Peters, et al.
Published: (2006-02-01)

The pleiotropic effects of paricalcitol: Beyond bone-mineral metabolism
by: Jesús Egido, et al.
Published: (2016-01-01)

Efficacy and safety of oral doxercalciferol in the management of secondary hyperparathyroidism in chronic kidney disease stage 4
by: P C Dheerendra, et al.
Published: (2013-01-01)

Longitudinal changes in bone and mineral metabolism after cessation of cinacalcet in dialysis patients with secondary hyperparathyroidism
by: Irene Ruderman, et al.
Published: (2018-05-01)

Quality of life of hemodialysis patients in Hong Kong.
Published: (1998)

Results of surgical treatment of uremic hyperparathyroidism (analysis 67 observations)
by: E. A. Il'icheva, et al.
Published: (2018-04-01)

Primary hyperparathyroidism clinical features on endocrinology in-patients clinic
by: I E Sapozhnikova
Published: (2018-10-01)